Coss AE, Granados J, Uribe M, Torre A

Idioma: Ingles.
Referencias bibliográficas: 19
Paginas: 28-32
Archivo PDF: 81.76 Kb.

RESUMEN

Sin resumen.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Doherty DG, Donalson PT, Underhill JA, Farrant JM, Duthie A, Mieli-Vergani G, et al. Allelic sequence variation in the HLA class II genes and proteins in patients with autoimmune hepatitis. Hepatology 1994; 19: 609-15.

2. Czaja AJ, Strettell MDJ, Thomson LJ, Santrach PJ, Moore SB, Donaldson PT, Williams R. Associations between alleles of the mayor hystocompatibility complex and type 1 autoimmune hepatitis. Hepatology 1997; 25: 317-23.

3. Lohse AW, Meyer zum Büchenfelde KH, Franz B, Kanzler S, Gerken G, Dienes HP. Characterization of the overlap syndrome of primary biliary cirrhosis (PBC) and autoimmune hepatitis: Evidence for it being a hepatitis form of PBC in genetically susceptible individuals. Hepatology 1999; 29: 1078-84.

4. Vázquez-García MN, Alaéz C, Olivo A, Debaz H, Pérez-Luque E, Burguete A, Cano S, et al. MHC class II sequences of susceptibility and protection in mexicans with autoinmune hepatitis. J Hepatol 1998; 28: 985-990.

5. Zepeda-Gomez S, Montaño-Loza A, Zapata-Colindres JC, Paz F, Olivera-Martinez M, López-Reyes A, Granados J, et al. HLA-DR allele frequencies in Mexican mestizos with autoimmune liver diseases including overlap syndromes. Immunol Invest 2009; 38(3-4): 276-83.

6. Alvarez F, Berg PA, Bianchi FB, Burroughs AK, Cancado EL, Chapman RW, et al. International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999; 31: 929-38.

7. Chazouillères O, Wendum D, Serfaty L, Montembault S, Rosmorduc O, Poupon R. Primary Biliary Cirrhosis-Autoimmune Hepatitis overlap syndrome: clinical features and response to therapy. Hepatology 1998; 28: 296-301.

8. Bignon JD, Fernández-Viña M, Arnajz-Villena A, Fauchet R, Weiss E, Powis S, et al. In: Charron D, Fauchet R (eds.). Technical handbook of the twelfth international histocompatibility workshop, HLA et Medicine, Paris: 1996.

9. Mackay IR, Morris PJ. Association of autoimmune active chronic hepatitis with HL-A1,8. Lancet 1972; 2: 793-5.

10. Page AR, Sharp HL, Greenberg LJ. Genetic analysis of patients with chronic active hepatitis. J Clin Invest 1975; 56: 530-5.

11. Williams RM, et al. Increased frequency of HLA-DRw4 in chronic active hepatitis. Vox Sang 1978; 35: 366-9.

12. Mackay IR, Tait BD. HLA associations with autoimmune type chronic active hepatitis: identification of B8-DRw3 haplotype by family studies. Gastroenterology 1980; 79: 95-8.

13. Cookson S, et al. Frequency and nature of cytokine gene polimorphisms in type 1 autoimmune hepatitis. Hepatology 1999; 30: 851-6.

14. Czaja AJ, Cookson S, Constantini PK, Clare M, Underhill JA, Donaldson PT. Cytokine polimorphisms associated with clinical features and treatment outcome in type 1 autoimmune hepatitis. Gastroenterology 1999; 177: 645-52.

15. Agarwal K, Czaja AJ, Jones DEJ, Donalson PT. CTLA-4 gene polimorphism confers susceptibility to type 1 autoimmune hepatitis. Hepatology 2000; 31: 49-53.

16. Czaja AJ. Genetic factors affecting the occurrence, clinical phenotype and outcome of autoimmune hepatitis. Clin Gastroenterol & Hepatol 2008; 6: 379-88.

17. Czaja AJ, Donaldson PT. Genetic susceptibilities for immune expression and liver cell injury in autoimmune hepatitis.

18. Czaja AJ, Santrach PJ, Moore SB. Shared genetic risk factors in autoimmune liver disease. Dig Dis Sci 2001; 46: 140-7.

19. Muratori P, Czaja AJ, Muratori L, Pappas G, Maccariello S, Cassini F, et al. Genetic distinctions between autoimmune hepatitis in Italy and North America. World J Gastroenterol 2005; 11(12):1862-6.